218 related articles for article (PubMed ID: 36588115)
21. PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.
Grabacka M; Placha W; Urbanska K; Laidler P; Płonka PM; Reiss K
Pigment Cell Melanoma Res; 2008 Jun; 21(3):388-96. PubMed ID: 18444964
[TBL] [Abstract][Full Text] [Related]
22. MITF-the first 25 years.
Goding CR; Arnheiter H
Genes Dev; 2019 Aug; 33(15-16):983-1007. PubMed ID: 31123060
[TBL] [Abstract][Full Text] [Related]
23. PPP6C, a serine-threonine phosphatase, regulates melanocyte differentiation and contributes to melanoma tumorigenesis through modulation of MITF activity.
Maskin CR; Raman R; Houvras Y
Sci Rep; 2022 Apr; 12(1):5573. PubMed ID: 35368039
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
[TBL] [Abstract][Full Text] [Related]
25. The tumor suppressor HINT1 regulates MITF and β-catenin transcriptional activity in melanoma cells.
Genovese G; Ghosh P; Li H; Rettino A; Sioletic S; Cittadini A; Sgambato A
Cell Cycle; 2012 Jun; 11(11):2206-15. PubMed ID: 22647378
[TBL] [Abstract][Full Text] [Related]
26. MITF, the Janus transcription factor of melanoma.
Koludrovic D; Davidson I
Future Oncol; 2013 Feb; 9(2):235-44. PubMed ID: 23414473
[TBL] [Abstract][Full Text] [Related]
27. BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene.
Saladi SV; Wong PG; Trivedi AR; Marathe HG; Keenen B; Aras S; Liew ZQ; Setaluri V; de la Serna IL
Pigment Cell Melanoma Res; 2013 May; 26(3):377-91. PubMed ID: 23480510
[TBL] [Abstract][Full Text] [Related]
28. Acetylation reprograms MITF target selectivity and residence time.
Louphrasitthiphol P; Loffreda A; Pogenberg V; Picaud S; Schepsky A; Friedrichsen H; Zeng Z; Lashgari A; Thomas B; Patton EE; Wilmanns M; Filippakopoulos P; Lambert JP; Steingrímsson E; Mazza D; Goding CR
Nat Commun; 2023 Sep; 14(1):6051. PubMed ID: 37770430
[TBL] [Abstract][Full Text] [Related]
29. MITF suppression by CH5552074 inhibits cell growth in melanoma cells.
Aida S; Sonobe Y; Yuhki M; Sakata K; Fujii T; Sakamoto H; Mizuno T
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1187-1193. PubMed ID: 28447210
[TBL] [Abstract][Full Text] [Related]
30. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
[TBL] [Abstract][Full Text] [Related]
31. CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanoma.
Berico P; Cigrang M; Davidson G; Braun C; Sandoz J; Legras S; Vokshi BH; Slovic N; Peyresaubes F; Gene Robles CM; Egly JM; Compe E; Davidson I; Coin F
EMBO Rep; 2021 Sep; 22(9):e51683. PubMed ID: 34296805
[TBL] [Abstract][Full Text] [Related]
32. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.
McGill GG; Horstmann M; Widlund HR; Du J; Motyckova G; Nishimura EK; Lin YL; Ramaswamy S; Avery W; Ding HF; Jordan SA; Jackson IJ; Korsmeyer SJ; Golub TR; Fisher DE
Cell; 2002 Jun; 109(6):707-18. PubMed ID: 12086670
[TBL] [Abstract][Full Text] [Related]
33. Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.
Chiu CS; Tsai CH; Hsieh MS; Tsai SC; Jan YJ; Lin WY; Lai DW; Wu SM; Hsing HY; Arbiser JL; Sheu ML
Cancer Lett; 2019 Feb; 442():113-125. PubMed ID: 30391358
[TBL] [Abstract][Full Text] [Related]
34. miR-148 regulates Mitf in melanoma cells.
Haflidadóttir BS; Bergsteinsdóttir K; Praetorius C; Steingrímsson E
PLoS One; 2010 Jul; 5(7):e11574. PubMed ID: 20644734
[TBL] [Abstract][Full Text] [Related]
35. Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells.
Sestáková B; Ondrusová L; Vachtenheim J
Pigment Cell Melanoma Res; 2010 Apr; 23(2):238-51. PubMed ID: 20067556
[TBL] [Abstract][Full Text] [Related]
36. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.
Du J; Miller AJ; Widlund HR; Horstmann MA; Ramaswamy S; Fisher DE
Am J Pathol; 2003 Jul; 163(1):333-43. PubMed ID: 12819038
[TBL] [Abstract][Full Text] [Related]
37. Regulation of MITF stability by the USP13 deubiquitinase.
Zhao X; Fiske B; Kawakami A; Li J; Fisher DE
Nat Commun; 2011 Aug; 2():414. PubMed ID: 21811243
[TBL] [Abstract][Full Text] [Related]
38. MITF activity is regulated by a direct interaction with RAF proteins in melanoma cells.
Estrada C; Mirabal-Ortega L; Méry L; Dingli F; Besse L; Messaoudi C; Loew D; Pouponnot C; Bertolotto C; Eychène A; Druillennec S
Commun Biol; 2022 Jan; 5(1):101. PubMed ID: 35091687
[TBL] [Abstract][Full Text] [Related]
39. Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma.
Gelmi MC; Verdijk RM; Houtzagers LE; van der Velden PA; Kroes WGM; Luyten GPM; Vu THK; Jager MJ
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240204
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma.
Miller AJ; Du J; Rowan S; Hershey CL; Widlund HR; Fisher DE
Cancer Res; 2004 Jan; 64(2):509-16. PubMed ID: 14744763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]